Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 481 articles: HTML format

Single Articles

October 2026
1. BEAVERS CJ, Dobesh PP, Cushman M, DiDomenico RJ, et al
   Multidisciplinary Approach to Antiplatelet Management in Coronary Syndromes: A Scientific Statement From the American Heart Association.
   Circulation. 2026 Oct 13. doi: 10.1161/CIR.0000000000001478.
   PubMed     Abstract available
   
   
   
2. PARK S, Gupta DK, Izzy M, VanWagner LB, et al
   Cardiovascular Complications of Chronic Liver Disease.
   Circulation. 2026;154:1518-1536.
   PubMed     Abstract available
   
   
   
3. LYON S, de Ferranti SD, Moran AE, Zhang Y, et al
   Trends and Distribution of Low-Density Lipoprotein Cholesterol Levels Among US Adults and Adolescents Without Atherosclerotic Cardiovascular Disease, 1999 to 2023.
   Circulation. 2026;154:1510-1514.
   PubMed    
   
   
   
4. LU CW
   Letter by Lu Regarding Article, "Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes".
   Circulation. 2026;154:e518-e519.
   PubMed    
   
   
   
5. CHO Y, Kang D, Shin JY, Choi KH, et al
   Response by Cho et al to Letters Regarding Article, "Association of Statin Discontinuation in Pregnancy with Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study".
   Circulation. 2026;154:e522-e523.
   PubMed    
   
   
   
6. STAVRAKIS S
   Vagal Nerve Stimulation for Cardiovascular Diseases: From Hype to Hope.
   Circulation. 2026;154:1287-1289.
   PubMed    
   
   
   
7. WANG Y, Li Y, Xing G
   Letter by Wang et al Regarding Article, "Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study".
   Circulation. 2026;154:e520-e521.
   PubMed    
   
   
   September 2026
8. GONG W, Li S, Zhang Z, Yan Y, et al
   Identification of Secreted Modular Calcium-Binding Protein 1 as a Novel Endogenous Protective Molecule Against Acute Myocardial Infarction-Induced Cardiac Rupture.
   Circulation. 2026 Sep 29. doi: 10.1161/CIRCULATIONAHA.126.079324.
   PubMed     Abstract available
   
   
   
9. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
   2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
   Circulation. 2026;154:e413-e504.
   PubMed     Abstract available
   
   
   
10. JONE PN, Newburger JW, Burns JC, Tomey MI, et al
    Acute Coronary Syndrome in Kawasaki Disease From Infancy to Adulthood.
    Circulation. 2026;154:1135-1150.
    PubMed     Abstract available
    
    
    
11. MADDOX TM
    Artificial Intelligence in Cardiovascular Science and Publishing.
    Circulation. 2026;154:1053-1055.
    PubMed    
    
    
    
12. QI MM, Wang MM
    Letter by Qi and Wang Regarding Article, "Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome".
    Circulation. 2026;154:e394-e395.
    PubMed    
    
    
    
13. EVERITT IK, Mukherjee M
    Giant Left Ventricular Pseudoaneurysm Complicating Myocardial Infarction.
    Circulation. 2026;154:1052.
    PubMed    
    
    
    
14. LANDI A, Malik FTN, Chieffo A, Valgimigli M, et al
    Clinical Management of Myocardial Infarction.
    Circulation. 2026;154:1036-1051.
    PubMed     Abstract available
    
    
    
15. LEONARDI S, Landi A, Valgimigli M
    Response by Leonardi et al to Letter Regarding Article, "Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome".
    Circulation. 2026;154:e396-e397.
    PubMed    
    
    
    
16. CONTRERAS J, Aguilar D, Bravo-Jaimes K, Cortes Y, et al
    State of Cardiovascular Disease and Stroke in Hispanic/Latino Adults in the United States: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Sep 15. doi: 10.1161/CIR.0000000000001463.
    PubMed     Abstract available
    
    
    
17. MOCUMBI AO
    The Future of Global Cardiovascular Health Research at Circulation.
    Circulation. 2026;154:963-965.
    PubMed    
    
    
    
18. PURI K, Allen K, Jentzer J, Soderstrom R, et al
    Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2026;154:e374-e392.
    PubMed     Abstract available
    
    
    
19. POWELL-WILEY TM
    Partnerships That Leverage Existing Community Strengths Are Key to Improving Cardiovascular Health.
    Circulation. 2026;154:876-878.
    PubMed    
    
    
    
20. DE BAKKER M, Thurston AJF, Hammarsten O, Khachatryan M, et al
    Macrotroponin Complexes and Risk of Cardiovascular Events.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.080483.
    PubMed     Abstract available
    
    
    
21. CHEN S, Shen S, Su W, Fu L, et al
    HNRNPK Lactylation Amplifies Inflammation and Exacerbates Myocardial Ischemia/Reperfusion Injury by Regulating Jag2 Splicing.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.081410.
    PubMed     Abstract available
    
    
    
22. DINEEN EH, Haigney MC, Levine BD, Ackerman MJ, et al
    Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.
    Circulation. 2026 Sep 3. doi: 10.1161/CIR.0000000000001476.
    PubMed     Abstract available
    
    
    
23. DEAN JL, Murphy CE, Franzos MA, Petek BJ, et al
    Cardiovascular Disease Risk Assessment in United States Military Service Members.
    Circulation. 2026 Sep 3. doi: 10.1161/CIRCULATIONAHA.126.081464.
    PubMed    
    
    
    
24. TANAKA T, Kawakami R, Gaynor BJ, Williams D, et al
    Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection.
    Circulation. 2026 Sep 1. doi: 10.1161/CIRCULATIONAHA.126.080495.
    PubMed     Abstract available
    
    
    
25. CARNETHON MR
    Searching for the Uncommon: The Future of Population Science in Cardiovascular Disease.
    Circulation. 2026;154:787-788.
    PubMed    
    
    
    August 2026
26. GIUGLIANO RP, Bohula EA, Bellavia A, De Ferrari GM, et al
    Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082436.
    PubMed     Abstract available
    
    
    
27. OSERAN AS, Wadhera RK
    The Last Mile of Cardiovascular Prevention: Evidence, Access, and Policy.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082918.
    PubMed    
    
    
    
28. JEEVANATHAN J, Thomas PE, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.079412.
    PubMed     Abstract available
    
    
    
29. KHAN SS, Post WS
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Risk: From Young to Older Adulthood.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082984.
    PubMed    
    
    
    
30. GUEDON AF, Cacoub P, Carrat F, Espitia O, et al
    Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
    Circulation. 2026 Aug 29. doi: 10.1161/CIRCULATIONAHA.126.080365.
    PubMed     Abstract available
    
    
    
31. LAUER MS
    Coronary Artery Calcium (CAC): From Marker to Treatment Target?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082642.
    PubMed    
    
    
    
32. DAVIS JW, Manson JE
    Cholecalciferol and Menaquinone Supplementation: Does Prevention of Coronary Artery Calcium Progression Mean Heart Benefit?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082639.
    PubMed    
    
    
    
33. HASIFIC S, Ovrehus KA, Mejldal A, Hosbond S, et al
    Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082363.
    PubMed     Abstract available
    
    
    
34. SUN G, Guo X, Zhao C, Ouyang N, et al
    Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082511.
    PubMed     Abstract available
    
    
    
35. MILLS NL (ESC CHAIRPERSON) (UN, Kristin Newby L (ACC/AHA Co-Chairperson) (United States of America), Zaman S (WHF Co-Chairperson) (Australia), Almahmeed
    Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Def
    Circulation. 2026 Aug 27. doi: 10.1161/CIR.0000000000001477.
    PubMed    
    
    
    
36. MA L, Hu Y, Liu G, Rexrode KM, et al
    Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2026 Aug 25:10.1161/CIRCULATIONAHA.126.079972.
    PubMed     Abstract available
    
    
    
37. LU B, Liu W, Ge Z, Zou J, et al
    Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction.
    Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.079049.
    PubMed     Abstract available
    
    
    
38. BOHULA EA, Morrow DA
    Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
    Circulation. 2026;154:775-784.
    PubMed     Abstract available
    
    
    
39. SRIVASTAVA M
    The Clinical Images in Cardiovascular Medicine Section.
    Circulation. 2026;154:785.
    PubMed    
    
    
    
40. DAI Y, Li Q, Ding F, Chen S, et al
    Site-Specific Apo AI Glycation Impairs HDL Function and Promotes Atherosclerosis in Diabetes.
    Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.078171.
    PubMed     Abstract available
    
    
    
41. PLUTZKY J, Bogdanski P, Colhoun HM, Dagdelen S, et al
    Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.
    Circulation. 2026 Aug 18. doi: 10.1161/CIRCULATIONAHA.125.074482.
    PubMed     Abstract available
    
    
    
42. MIAO ZW, Chen CX, Wang P, Zheng SL, et al
    Metrnl Reduces Thrombosis and Acute Myocardial Injury Through Inhibition of Platelet Activation via CD36 Receptor Degradation.
    Circulation. 2026 Aug 18. doi: 10.1161/CIRCULATIONAHA.126.077134.
    PubMed     Abstract available
    
    
    
43. LIU Y, Chen Y, Zheng H, Li Y, et al
    ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction.
    Circulation. 2026 Aug 11. doi: 10.1161/CIRCULATIONAHA.125.078593.
    PubMed     Abstract available
    
    
    
44. ZHOU S, Liu J, Hu M, Tian S, et al
    Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2026 Aug 4. doi: 10.1161/CIRCULATIONAHA.125.077971.
    PubMed     Abstract available
    
    
    
45. SALEM AR, Kumar A, Doja J, Wally A, et al
    Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis.
    Circulation. 2026 Aug 4:10.1161/CIRCULATIONAHA.126.080105.
    PubMed     Abstract available
    
    
    
46. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Correction to: Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States through 2050: A Scientific Statement from the American Heart Association.
    Circulation. 2026;154:e233-e234.
    PubMed    
    
    
    
47. WU JC
    Perspectives on the Future of Fundamental Sciences in Cardiovascular Medicine.
    Circulation. 2026;154:425-427.
    PubMed    
    
    
    
48. RAISI-ESTABRAGH Z, Petersen SE, Neubauer S
    Ten Years of Scientific Discovery With the UK Biobank Cardiovascular Magnetic Resonance Imaging Study.
    Circulation. 2026;154:490-511.
    PubMed     Abstract available
    
    
    
49. GAUDINO M, Sandner S, Bagiella E, Beckman JA, et al
    Methodologic Standards for Follow-Up Extension in Cardiovascular Trials: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Aug 3. doi: 10.1161/CIR.0000000000001458.
    PubMed     Abstract available
    
    
    July 2026
50. VERGHESE D, Trujillo R, Abraham D, McClelland RL, et al
    Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events.
    Circulation. 2026;154:302-312.
    PubMed     Abstract available
    
    
    
51. NDUMELE CE, Rangaswami J, Rodriguez F
    Cardiovascular-Kidney-Metabolic Syndrome: A User's Guide to the Guidelines.
    Circulation. 2026;154:409-412.
    PubMed    
    
    
    
52. POWELL-WILEY TM, Williams M, Davis EM
    Telehealth for Community-Engaged Cardiovascular Care in Rural Populations.
    Circulation. 2026;154:400-404.
    PubMed    
    
    
    
53. HUFFMAN MD, Vijay A, Mahmoud Z
    2026 Cardiovascular-Kidney-Metabolic Guidelines: Practical Implementation Strategies.
    Circulation. 2026;154:413-415.
    PubMed    
    
    
    
54. LLOYD-JONES DM
    Cardiovascular-Kidney-Metabolic Syndrome: A Historic Perspective.
    Circulation. 2026;154:416-419.
    PubMed    
    
    
    
55. GANESH A, Sujanthan S, Muir RT, Joundi RA, et al
    Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke.
    Circulation. 2026;154:378-394.
    PubMed     Abstract available
    
    
    
56. RODRIGUEZ F, Langlotz CP
    Opportunistic Coronary Artery Calcium Screening: Time for Clinical Implementation.
    Circulation. 2026;154:313-315.
    PubMed    
    
    
    
57. BREWER LC, Joseph JJ, Cooper LA
    Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome.
    Circulation. 2026;154:405-408.
    PubMed    
    
    
    
58. STEINHAUSER ML
    Translational Cardiovascular Science for the Circulation Community.
    Circulation. 2026;154:299-300.
    PubMed    
    
    
    
59. MARCUS GM, Hu FB, van Dam RM, Cornelis MC, et al
    Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jul 20. doi: 10.1161/CIR.0000000000001454.
    PubMed     Abstract available
    
    
    
60. JOYNT MADDOX KE
    An Integrated Ecosystem for Cardiovascular Science and Health.
    Circulation. 2026;154:85-87.
    PubMed    
    
    
    
61. GENTILE F, Emdin M, Clemente A
    Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e22-e23.
    PubMed    
    
    
    
62. HAN QJ, Stefanescu Schmidt AC, DeFaria Yeh D
    Letter by Han et al Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e18-e19.
    PubMed    
    
    
    
63. LI Q, Zhang P
    Letter by Li and Zhang Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e20-e21.
    PubMed    
    
    
    
64. ITCHHAPORIA D, Yancy CW, Rosen SE, Mbakwem AC, et al
    Cardiovascular Health Equity: Time for a New Era of Science, Sociology, and Interventions.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001445.
    PubMed    
    
    
    
65. DIDOMENICO RJ, Marrs JC, Bress AP, Denfeld QE, et al
    Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001459.
    PubMed     Abstract available
    
    
    
66. XIONG Z, Li Y, Zhang Y, Ma Z, et al
    RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury.
    Circulation. 2026;154:37-57.
    PubMed     Abstract available
    
    
    
67. PIGEYRE M, Gerstein HC
    Cardiovascular Risk Reduction With GLP-1 RA Drugs.
    Circulation. 2026;154:66-73.
    PubMed     Abstract available
    
    
    June 2026
68. MO D, Dai H
    Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy.
    Circulation. 2026;153:1949-1951.
    PubMed    
    
    
    
69. BRANDT EJ, Carnethon MR, Watson KE
    Disparities in Cardiovascular Medicine: Evidence Is Not Enough, Policy Change Is Essential.
    Circulation. 2026;153:1877-1878.
    PubMed    
    
    
    
70. ZIAEIAN B, Fonarow GC
    Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal Progress.
    Circulation. 2026;153:1879-1881.
    PubMed    
    
    
    
71. ESSIEN UR, Joynt Maddox KE, Dusetzina SB
    Pharmacoequity and the Promise of GLP-1 Therapies in Cardiovascular Disease.
    Circulation. 2026;153:1884-1886.
    PubMed    
    
    
    
72. NARASIMMARAJ PR, Vyas DA, Wadhera RK
    The Cardiovascular Cost of Medicaid Cuts Under H.R. 1.
    Circulation. 2026;153:1882-1883.
    PubMed    
    
    
    
73. BARAC A, Guha A, Fleming TR, Bonaca M, et al
    Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jun 15. doi: 10.1161/CIR.0000000000001417.
    PubMed     Abstract available
    
    
    
74. SPAULDING C, Krackhardt F, Bogaerts K, Abdelaal E, et al
    Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.
    Circulation. 2026 Jun 15. doi: 10.1161/CIRCULATIONAHA.126.079033.
    PubMed     Abstract available
    
    
    
75. ZEITOUNI M, Procopi N, Cayla G, Ferrari E, et al
    Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by beta-Blockers: A Secondary Analysis of the ABYSS Trial.
    Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.078635.
    PubMed     Abstract available
    
    
    
76. AHMED-JUSHUF F, Foley MJ, Chotai S, Rajkumar CA, et al
    Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study.
    Circulation. 2026;153:1795-1812.
    PubMed     Abstract available
    
    
    
77. NDUMELE CE, Rodriguez F, Dixon DL, Khan SS, et al
    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001453.
    PubMed     Abstract available
    
    
    
78. KHAN SS, Bhave N, Blumenthal RS, Coresh J, et al
    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001447.
    PubMed     Abstract available
    
    
    
79. MURPHY SA, Bellavia A
    Total Event Analysis in Cardiovascular Outcome Trials: Approaches and Interpretation.
    Circulation. 2026;153:1789-1791.
    PubMed    
    
    
    
80. BLANKSTEIN R, Blaha MJ, Post WS
    Should Coronary CT Angiography or Coronary Artery Calcium Testing Be Used to Guide Primary Prevention?
    Circulation. 2026;153:1691-1693.
    PubMed    
    
    
    May 2026
81. WINTERS AH, Kelly MA, Syed MG, Bergquist T, et al
    A Genome-First Study of Familial Hypercholesterolemia Comparing African and European Ancestry Individuals.
    Circulation. 2026 May 29. doi: 10.1161/CIRCULATIONAHA.126.080694.
    PubMed     Abstract available
    
    
    
82. BARNES GD, Lech T, Allen AL
    Anticoagulation Services as a Model for Cardiovascular Medication Stewardship.
    Circulation. 2026;153:1603-1605.
    PubMed    
    
    
    
83. FERREIRA ZIMMER C, Marquard JM, Jabbari R, Sabbah M, et al
    Impact of Angina on Outcome After Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation: Insights From the NOTION-3 Trial.
    Circulation. 2026;153:1687-1690.
    PubMed    
    
    
    
84. LIU K, Yao K
    Letter by Liu and Yao Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1340-e1341.
    PubMed    
    
    
    
85. CROON PM, Khera R
    Response by Croon and Khera to Letter Regarding Article, "Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction".
    Circulation. 2026;153:e1342-e1343.
    PubMed    
    
    
    
86. MONGUILLON V, Marston NA, Bohula EA, Park JG, et al
    Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.
    Circulation. 2026 May 25. doi: 10.1161/CIRCULATIONAHA.126.080999.
    PubMed     Abstract available
    
    
    
87. BALLIN M, Carlsson AC, Wandell P, Ahlqvist VH, et al
    Adolescent Cardiorespiratory Fitness and the Trade-Off Between Atrial Fibrillation Risk and Cardiovascular Benefits: A Nationwide Sibling-Controlled Cohort Study.
    Circulation. 2026 May 21. doi: 10.1161/CIRCULATIONAHA.125.078250.
    PubMed     Abstract available
    
    
    
88. MAC GRORY B, Yeh RW, Beckman JA, Kamel H, et al
    Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 20. doi: 10.1161/CIR.0000000000001440.
    PubMed     Abstract available
    
    
    
89. CHEN BY, Duan SZ
    Response by Chen and Duan to Letter Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1338-e1339.
    PubMed    
    
    
    
90. PAN Y, Ding J
    Letter by Pan and Ding Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1336-e1337.
    PubMed    
    
    
    
91. FISTER M, Noc M, Radsel P, Bunc M, et al
    Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial.
    Circulation. 2026;153:1526-1534.
    PubMed     Abstract available
    
    
    
92. BERGMARK BA, Bohula EA, Marston NA, Park JG, et al
    Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
    Circulation. 2026 May 19. doi: 10.1161/CIRCULATIONAHA.126.080616.
    PubMed     Abstract available
    
    
    
93. LALANI C, Dahabreh IJ, Cohen DJ, Kazi DS, et al
    Evaluating Cardiovascular Devices Using Observational Analyses.
    Circulation. 2026;153:1573-1592.
    PubMed     Abstract available
    
    
    
94. DESPRES JP, Neeland IJ
    Incretin-Based Therapies and Cardiovascular Outcomes: Beyond Weight Loss.
    Circulation. 2026;153:1523-1525.
    PubMed    
    
    
    
95. ABBOTT JD, Benatar JR, Ballantyne CM, Jacobs AK, et al
    Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.
    Circulation. 2026 May 18. doi: 10.1161/CIRCULATIONAHA.125.078320.
    PubMed     Abstract available
    
    
    
96. RUEL M, Sandner S, Ponnambalam M, Brown C, et al
    Secondary Prevention After Coronary Artery Bypass Graft Surgery: 2026 Update: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 13. doi: 10.1161/CIR.0000000000001434.
    PubMed     Abstract available
    
    
    
97. ZHANG L, Chen Y, Xu P, Zheng T, et al
    CD40-TRAF2/3/5 Signaling Promotes Cardiac Repair by Mediating Macrophage Efferocytosis After Myocardial Infarction.
    Circulation. 2026 May 7. doi: 10.1161/CIRCULATIONAHA.125.078873.
    PubMed     Abstract available
    
    
    April 2026
98. ZHU K, Guo J, Liu Y, Li J, et al
    TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
    Circulation. 2026;153:1314-1336.
    PubMed     Abstract available
    
    
    
99. ZHANG B, Sun A, Ge J
    Intracellular TRPM7-Mediated Zn(2+) Release: A Novel Pyroptotic Axis in Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2026;153:1230-1232.
    PubMed    
    
    
    
100. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
     Response by Mori et al to Letter Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
     Circulation. 2026;153:e1128-e1129.
     PubMed    
     
     
     
101. LUO Y, Zhao J, Dong Q
     Letter by Luo et al Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
     Circulation. 2026;153:e1126-e1127.
     PubMed    
     
     
     
102. SHUOLIN L, Chuanyin L, Zhu M, Zhu T, et al
     Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity.
     Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.125.074399.
     PubMed     Abstract available
     
     
     
103. ZHUANG Z, Huang J, Chi H
     Letter by Zhuang et al Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
     Circulation. 2026;153:e1117-e1118.
     PubMed    
     
     
     
104. MURCHLAND AR, Koenen KC, Lawn RB
     Response by Murchland et al to Letter Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
     Circulation. 2026;153:e1119-e1120.
     PubMed    
     
     
     
105. STEPANIAN A, Jaffe IZ
     Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
     Circulation. 2026;153:e1113-e1114.
     PubMed    
     
     
     
106. ZHENG T, Yuan X, Liu H
     Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
     Circulation. 2026;153:e1109-e1110.
     PubMed    
     
     
     
107. XU X, Zhang S, Bao L
     Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
     Circulation. 2026;153:e1111-e1112.
     PubMed    
     
     
     
108. LIU C, Li X
     Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
     Circulation. 2026;153:e1107-e1108.
     PubMed    
     
     
     
109. SCHRAMA TJ, Aengevaeren VL
     Disentangling the Relationship Between Exercise and Coronary Atherosclerosis: Wearable Training Data Are the Way Forward.
     Circulation. 2026;153:1023-1025.
     PubMed    
     
     
     
110. KUYUCU I, Canavar OF, Dogruer RD, Altin AD, et al
     Correction to: Abstract 4367615: The Cardiovascular Paradox of Gout Prophylaxis: A Systematic Review and Meta-analysis.
     Circulation. 2026;153:e1116.
     PubMed    
     
     
     
111. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
     Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
     Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
     PubMed     Abstract available
     
     
     March 2026
112. LI L
     Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue.
     Circulation. 2026;153:998-1000.
     PubMed    
     
     
     
113. ZHANG M, Qin Y, Zhou T, Liu M, et al
     Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
     Circulation. 2026;153:983-997.
     PubMed     Abstract available
     
     
     
114. LICHTENSTEIN AH, Khera A, Anderson CAM, Appel LJ, et al
     2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Mar 31. doi: 10.1161/CIR.0000000000001435.
     PubMed     Abstract available
     
     
     
115. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
     Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2026;153:e1106.
     PubMed    
     
     
     
116. BELLAVIA A, Murphy SA
     Competing Risks in Cardiovascular Research: A Practical Perspective.
     Circulation. 2026;153:945-947.
     PubMed    
     
     
     
117. HUNDEMER GL, Vaidya A
     Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
     Circulation. 2026;153:e1053-e1054.
     PubMed    
     
     
     
118. XU J, Sun Y
     Letter by Xu and Sun Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
     Circulation. 2026;153:e1052.
     PubMed    
     
     
     
119. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
     Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
     Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
     PubMed     Abstract available
     
     
     
120. MARSTON NA, Bergmark BA, Prohaska TA, Moura FA, et al
     Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.
     Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012.
     PubMed     Abstract available
     
     
     
121. REYNOLDS HR, Maehara A, Heydari B, Smilowitz NR, et al
     Multi-modality Imaging to Determine Underlying Causes of MINOCA in Women and Men.
     Circulation. 2026 Mar 28. doi: 10.1161/CIRCULATIONAHA.126.080234.
     PubMed     Abstract available
     
     
     
122. HANNEMAN K, Alahmad B, Ghosh A, Khatana SAM, et al
     Nonoptimal Temperature and Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Mar 26. doi: 10.1161/CIR.0000000000001419.
     PubMed     Abstract available
     
     
     
123. SUN S, Zhang X, Yue H, Fan C, et al
     The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis.
     Circulation. 2026;153:902-921.
     PubMed     Abstract available
     
     
     
124. DENG KQ, Xu Z, Wang Q, Cai HH, et al
     Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
     Circulation. 2026;153:826-844.
     PubMed     Abstract available
     
     
     
125. DHRUVA SS
     Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk.
     Circulation. 2026;153:807-809.
     PubMed    
     
     
     
126. WATSON KE, Fonarow GC
     The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment.
     Circulation. 2026 Mar 13. doi: 10.1161/CIRCULATIONAHA.126.079538.
     PubMed    
     
     
     
127. ZHU X, Li W, Yu J
     Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
     Circulation. 2026;153:e913.
     PubMed    
     
     
     
128. CHU L, Ma X, Chen K
     Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
     Circulation. 2026;153:e914-e915.
     PubMed    
     
     
     
129. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
     Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
     Circulation. 2026;153:696-698.
     PubMed    
     
     
     
130. HE J, Zhu Y
     Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
     Circulation. 2026;153:e909.
     PubMed    
     
     
     
131. JARR KU, Peters A, Leeper NJ
     Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
     Circulation. 2026;153:613-615.
     PubMed    
     
     
     February 2026
132. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
     PubMed     Abstract available
     
     
     
133. XIE J, Cheng LM, Liu K
     Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e109-e110.
     PubMed    
     
     
     
134. HUANG J, Fogacci F
     Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e111-e112.
     PubMed    
     
     
     
135. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
     Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
     Circulation. 2026;153:e113-e114.
     PubMed    
     
     
     
136. CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
     Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease.
     Circulation. 2026;153:467-468.
     PubMed    
     
     
     
137. GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
     Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
     Circulation. 2026;153:543-546.
     PubMed    
     
     
     
138. ROSEN SE
     Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How Does Sex Matter?".
     Circulation. 2026;153:534-535.
     PubMed    
     
     
     
139. BOYER TM, Barrett RB, Xiong C, Bu F, et al
     Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
     Circulation. 2026;153:480-492.
     PubMed     Abstract available
     
     
     
140. LI N, Hao Z, Yang H, Cai J, et al
     CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
     Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
     PubMed     Abstract available
     
     
     
141. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
     Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
     Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
     PubMed     Abstract available
     
     
     
142. BAI X, Ren R, Yuan J, Yu L, et al
     Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
     Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
     PubMed     Abstract available
     
     
     
143. KHAN SS, Greenland P, Hayman LL, Khera R, et al
     Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
     PubMed     Abstract available
     
     
     
144. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
     Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
     Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
     PubMed     Abstract available
     
     
     
145. ZHAO L, Zhao C, Wang Y
     Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
     Circulation. 2026;153:e71-e72.
     PubMed    
     
     
     
146. HUANG Q, Jian X, Wu F
     Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
     Circulation. 2026;153:e69-e70.
     PubMed    
     
     
     
147. WU Y, Nguyen T, Wang Y, Zhou Y, et al
     Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
     Circulation. 2026;153:463-466.
     PubMed    
     
     
     
148. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
     Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
     PubMed     Abstract available
     
     
     
149. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
     Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
     Circulation. 2026;153:435-456.
     PubMed     Abstract available
     
     
     
150. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
     Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
     PubMed     Abstract available
     
     
     
151. LI X, Li X, Li CX, Feng J, et al
     TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.
     Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074791.
     PubMed     Abstract available
     
     
     
152. BANGALORE S, Fearon WF, Fugar S, Dangas GD, et al
     Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.
     Circulation. 2026;153:e25-e41.
     PubMed     Abstract available
     
     
     
153. KOVACIC JC, Reynolds HR, Alasnag M, Blakeman JR, et al
     Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
     Circulation. 2026 Feb 3. doi: 10.1161/CIR.0000000000001416.
     PubMed     Abstract available
     
     
     January 2026
154. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
     Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
     Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
     PubMed     Abstract available
     
     
     
155. CHANG Q, Li C, Xu Z
     An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
     Circulation. 2026;153:282-284.
     PubMed    
     
     
     
156. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
     Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
     Circulation. 2026;153:266-281.
     PubMed     Abstract available
     
     
     
157. CHO Y, Kang D, Lim H, Lee H, et al
     Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
     Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
     PubMed     Abstract available
     
     
     
158. HE J, Zhu Y
     Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
     Circulation. 2026;153:185-188.
     PubMed    
     
     
     
159. PYRPYRIS N, Dimitriadis K, Tsioufis K
     Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
     Circulation. 2026;153:e14-e15.
     PubMed    
     
     
     
160. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
     Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
     Circulation. 2026;153:e17-e18.
     PubMed    
     
     
     
161. SUN P
     Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
     Circulation. 2026;153:e16.
     PubMed    
     
     
     
162. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
     Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
     Circulation. 2026;153:e19.
     PubMed    
     
     
     
163. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
     Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
     Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
     PubMed     Abstract available
     
     
     
164. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
     Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
     Circulation. 2026;153:e11.
     PubMed    
     
     
     
165. SITTICHOKKANANON A, Garfield V, Chiesa ST
     Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
     Circulation. 2026;153:e6-e7.
     PubMed    
     
     
     
166. YANG S, Lu Y
     Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
     Circulation. 2026;153:e4-e5.
     PubMed    
     
     
     
167. ZHAO YT
     Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
     Circulation. 2026;153:e8-e9.
     PubMed    
     
     
     
168. FEARON WF, Terada K, Takahashi K, Skoda A, et al
     Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
     Circulation. 2026;153:7-17.
     PubMed     Abstract available
     
     
     
169. LEONARDI S, Landi A, Zito A, Branca M, et al
     Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
     Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
     PubMed     Abstract available
     
     
     December 2025
170. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
     Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
     Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
     PubMed    
     
     
     
171. HENRIKSEN PA
     Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
     Circulation. 2025;152:1756-1758.
     PubMed    
     
     
     
172. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
     Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
     PubMed     Abstract available
     
     
     
173. XU L, Hrybouski S, Liao TE, Dong JN, et al
     Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
     Circulation. 2025;152:1608-1620.
     PubMed     Abstract available
     
     
     
174. SHARIF A
     Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
     Circulation. 2025;152:1591-1593.
     PubMed    
     
     
     
175. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
     Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
     Circulation. 2025;152:1586-1589.
     PubMed    
     
     
     
176. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
     The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
     Circulation. 2025;152:1541-1551.
     PubMed     Abstract available
     
     
     
177. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
     Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
     PubMed     Abstract available
     
     
     
178. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
     Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
     Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
     PubMed     Abstract available
     
     
     November 2025
179. CHEN Y
     Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
     Circulation. 2025;152:e407.
     PubMed    
     
     
     
180. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
     Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
     Circulation. 2025;152:1423-1435.
     PubMed     Abstract available
     
     
     
181. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
     Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
     PubMed     Abstract available
     
     
     
182. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
     Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
     Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
     PubMed     Abstract available
     
     
     
183. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;152:e402.
     PubMed    
     
     
     
184. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
     miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
     Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
     PubMed     Abstract available
     
     
     
185. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
     Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
     Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
     PubMed    
     
     
     
186. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
     High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
     Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
     PubMed     Abstract available
     
     
     
187. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
     State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
     PubMed     Abstract available
     
     
     
188. LEMESLE G, Didier R, Diallo A, Dromas H, et al
     Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
     Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
     PubMed    
     
     
     
189. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
     Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
     Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
     PubMed     Abstract available
     
     
     
190. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
     Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
     Circulation. 2025;152:e371.
     PubMed    
     
     
     October 2025
191. RUEL M
     Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2025;152:1187.
     PubMed    
     
     
     
192. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
     Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
193. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
     Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
194. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
     Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
195. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
     Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
196. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
     Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
197. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
     Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
198. CAO D, Arens AM, Chow SL, Easter SR, et al
     Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
199. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
     Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
200. LEE HC, Strand ML, Finan E, Illuzzi J, et al
     Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
201. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
     Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
202. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
     Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
203. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
     Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
     Circulation. 2025;152.
     PubMed     Abstract available
     
     
     
204. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
     Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
     Circulation. 2025;152:e296-e297.
     PubMed    
     
     
     
205. KING SJ, Furst A, Fan J, Chen TP, et al
     Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
     Circulation. 2025;152:1183-1185.
     PubMed    
     
     
     
206. KORNELIUS E
     Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
     Circulation. 2025;152:e295.
     PubMed    
     
     
     
207. KOLE A, Joshi PH
     Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
     Circulation. 2025;152:1123-1125.
     PubMed    
     
     
     
208. REGAN JA, Laitner MH, Dzau VJ
     A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
     Circulation. 2025;152:1166-1173.
     PubMed     Abstract available
     
     
     
209. CHEN X, Yu X, Zhong S, Sha P, et al
     ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
     Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
     PubMed     Abstract available
     
     
     
210. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
     Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
     PubMed     Abstract available
     
     
     
211. KHAN SS, Fisher SA
     Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
     Circulation. 2025;152:1056-1059.
     PubMed    
     
     
     
212. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
     Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
     Circulation. 2025;152:1044-1055.
     PubMed     Abstract available
     
     
     
213. OREN O, Libby P
     Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
     Circulation. 2025;152:975-977.
     PubMed    
     
     
     September 2025
214. VONGPATANASIN W, Abraham J, Giacona JM
     Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
     Circulation. 2025;152:924-926.
     PubMed    
     
     
     
215. SECHI LA, Bulfone L, Catena C
     Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
     Circulation. 2025;152:e265-e266.
     PubMed    
     
     
     
216. BHATIA HS, Tsimikas S
     Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
     Circulation. 2025;152:e267-e268.
     PubMed    
     
     
     
217. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
     Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
     Circulation. 2025;152:971-973.
     PubMed    
     
     
     
218. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
     Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
     Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
     PubMed     Abstract available
     
     
     
219. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
     Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
     Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
     PubMed     Abstract available
     
     
     
220. GAN J, Zhao R, Zheng D, Peng Y, et al
     PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
     Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
     PubMed     Abstract available
     
     
     
221. FENG S, Wang Z, Sun R
     Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e239-e240.
     PubMed    
     
     
     
222. ZHONG Y, Lai R, Deng X
     Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e241-e242.
     PubMed    
     
     
     
223. JI Y, Chen LY, Zhang MJ
     Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e243-e244.
     PubMed    
     
     
     
224. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
     Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
     PubMed     Abstract available
     
     
     
225. COUTINHO T
     The Geometry of Aging: New Angles on Cardiovascular Risk.
     Circulation. 2025;152:762-764.
     PubMed    
     
     
     
226. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
     Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
     Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
     PubMed     Abstract available
     
     
     
227. SHI F, Zheng B, Liu Y
     Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e71-e72.
     PubMed    
     
     
     
228. NAMBI V, de Lemos JA, Ballantyne CM
     A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
     Circulation. 2025;152:567-569.
     PubMed    
     
     
     
229. KUEHN BM
     Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
     Circulation. 2025;152:630-631.
     PubMed    
     
     
     
230. SILBERNAGEL G, Wen Y, Konrad RJ
     Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e73-e74.
     PubMed    
     
     
     
231. HUANG J
     Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e69-e70.
     PubMed    
     
     
     
232. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
     Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
     Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
     PubMed     Abstract available
     
     
     August 2025
233. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
     Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
     PubMed     Abstract available
     
     
     
234. CHEN BY, Zhu H, Li YL, Zhang J, et al
     Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
     Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
     PubMed     Abstract available
     
     
     
235. WU J, Zheng Y
     Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e67.
     PubMed    
     
     
     
236. HO FK, Sattar N, Welsh P
     Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e68.
     PubMed    
     
     
     
237. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
     Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
     Circulation. 2025;152:486-488.
     PubMed    
     
     
     
238. BERRY C, Carberry J, Dharmakumar R
     Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
     Circulation. 2025;152:349-351.
     PubMed    
     
     
     
239. VIDOT DC
     Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
     Circulation. 2025;152:366-368.
     PubMed    
     
     
     
240. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
     Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
     Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
     PubMed     Abstract available
     
     
     
241. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
     Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
     Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
     PubMed     Abstract available
     
     
     
242. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
     The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
     Circulation. 2025;152:346-348.
     PubMed    
     
     
     
243. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
     Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
     PubMed     Abstract available
     
     
     July 2025
244. WERESKI R, Morrow DA, Mills NL
     Unstable Angina Refined.
     Circulation. 2025;152:213-216.
     PubMed    
     
     
     
245. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
     CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
     Circulation. 2025;152:257-273.
     PubMed     Abstract available
     
     
     
246. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
     Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
     Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
     PubMed     Abstract available
     
     
     
247. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
     Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
     Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
     PubMed     Abstract available
     
     
     
248. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
     DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
     Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
     PubMed     Abstract available
     
     
     
249. BANN GG, Dos Santos M, Chen K, Tan W, et al
     Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
     Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
     PubMed     Abstract available
     
     
     
250. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
     Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
     Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
     PubMed     Abstract available
     
     
     
251. HU Q, Zhang J, Luo X, Hu P, et al
     Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2025;152:41-57.
     PubMed     Abstract available
     
     
     
252. HENDREN NS, Ammirati E
     Cardiovascular Effects of COVID-19: Legacy and Future Insights.
     Circulation. 2025;152:24-26.
     PubMed    
     
     
     
253. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
     The State of Cardiovascular Care in Peru: Needs for System Strengthening.
     Circulation. 2025;152:7-10.
     PubMed    
     
     
     June 2025
254. GONG Y, Lu X, Wang X, Wang Y, et al
     Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
     Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
     PubMed     Abstract available
     
     
     
255. DUAN Z, Lin Z
     Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1093-e1094.
     PubMed    
     
     
     
256. THRANE PG, Maeng M, Maehara A, Botker HE, et al
     Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
     Circulation. 2025;151:1767-1779.
     PubMed     Abstract available
     
     
     
257. WANG H, Zhao T, Zheng G
     Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1091-e1092.
     PubMed    
     
     
     
258. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e1098.
     PubMed    
     
     
     
259. BELLAVIA A, Murphy SA
     Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
     Circulation. 2025;151:1755-1757.
     PubMed    
     
     
     
260. JOHNY E, Dutta P
     Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
     Circulation. 2025;151:1748-1751.
     PubMed    
     
     
     
261. ARNAOUT R
     From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
     Circulation. 2025;151:1697-1698.
     PubMed    
     
     
     
262. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
     Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
     Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
     PubMed     Abstract available
     
     
     
263. CAMPO G, Pavasini R
     Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1049-e1050.
     PubMed    
     
     
     
264. PAN D, Wu W, Chen M
     Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1047-e1048.
     PubMed    
     
     
     
265. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
     Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
     PubMed     Abstract available
     
     
     
266. LEE S, Hwang SH, Park S, Son Y, et al
     Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
     PubMed     Abstract available
     
     
     
267. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
     Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
     PubMed     Abstract available
     
     
     
268. CHU L, Wang R, Gross CP, Wei J, et al
     Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
     Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
     PubMed     Abstract available
     
     
     
269. GREGSON J, Taylor D, Owen R, Collier T, et al
     Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
     Circulation. 2025;151:1606-1619.
     PubMed     Abstract available
     
     
     May 2025
270. SCHNEEWEISS S, Kruger N
     Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
     Circulation. 2025;151:1495-1497.
     PubMed    
     
     
     
271. BERRY C, McCartney P
     Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
     Circulation. 2025;151:e1002-e1003.
     PubMed    
     
     
     
272. BULLUCK H, Hausenloy DJ
     Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
     Circulation. 2025;151:e1004-e1005.
     PubMed    
     
     
     
273. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
     Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
     Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
     PubMed     Abstract available
     
     
     
274. ZHANG Z, Yang X, Zhang Z
     Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e986-e987.
     PubMed    
     
     
     
275. REITAN C, Andell P, Hofmann R, Jernberg T, et al
     Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e988-e989.
     PubMed    
     
     
     
276. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025;151:e1000.
     PubMed    
     
     
     
277. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
     The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
     Circulation. 2025;151:1430-1432.
     PubMed    
     
     
     April 2025
278. CLARKE R, Wright N, Lin K, Yu C, et al
     Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
     Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
     PubMed     Abstract available
     
     
     
279. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2025;151:e965-e966.
     PubMed    
     
     
     
280. DONG J, Yang X, Zhang W
     Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e962-e963.
     PubMed    
     
     
     
281. BONNESEN K, Heide-Jorgensen U, Schmidt M
     Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e964.
     PubMed    
     
     
     
282. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
     Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
     PubMed     Abstract available
     
     
     
283. LV H, Wang C, Liu Z, Quan M, et al
     Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
     PubMed     Abstract available
     
     
     
284. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
     High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
     Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
     PubMed     Abstract available
     
     
     
285. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
     Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
     PubMed     Abstract available
     
     
     
286. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
     Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
     Circulation. 2025;151:1063-1075.
     PubMed     Abstract available
     
     
     
287. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
     PubMed     Abstract available
     
     
     
288. CHEN Q, Zheng A, Xu X, Shi Z, et al
     Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
     Circulation. 2025;151:1024-1046.
     PubMed     Abstract available
     
     
     
289. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
     Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
     Circulation. 2025;151:1009-1023.
     PubMed     Abstract available
     
     
     
290. BENOWITZ NL
     Predicting Cardiovascular Risk With Use of Various Tobacco Products.
     Circulation. 2025;151:1006-1008.
     PubMed    
     
     
     
291. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
     Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
     Circulation. 2025;151:1047-1050.
     PubMed    
     
     
     
292. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
     Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
     PubMed     Abstract available
     
     
     
293. SITTICHOKKANANON A, Garfield V, Chiesa ST
     Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
     Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
     PubMed     Abstract available
     
     
     
294. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e865.
     PubMed    
     
     
     
295. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025;151:e864.
     PubMed    
     
     
     
296. YU M, Cheng X
     Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e769-e770.
     PubMed    
     
     
     
297. KAKIZAKI R, Raber L
     Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e767-e768.
     PubMed    
     
     
     March 2025
298. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
     Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
     Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
     PubMed     Abstract available
     
     
     
299. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
     Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
     Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
     PubMed    
     
     
     
300. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
     Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
     PubMed     Abstract available
     
     
     
301. NDUMELE CE, Ferdinand KC, Khan SS
     The Role of Race in Cardiovascular Disease Risk Prediction.
     Circulation. 2025;151:741-743.
     PubMed    
     
     
     
302. HULL LE, Aday AW, Bui QM, Luzum JA, et al
     Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
     PubMed     Abstract available
     
     
     
303. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
     Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
     Circulation. 2025;151:672-685.
     PubMed     Abstract available
     
     
     
304. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2025;151:e709.
     PubMed    
     
     
     
305. CLAUDEL SE, Verma A
     Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
     Circulation. 2025;151:716-732.
     PubMed     Abstract available
     
     
     
306. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
     Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
     Circulation. 2025;151:612-622.
     PubMed     Abstract available
     
     
     
307. KOU S, Lu Z, Deng D, Ye M, et al
     Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
     Circulation. 2025;151:623-639.
     PubMed     Abstract available
     
     
     February 2025
308. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
     PubMed     Abstract available
     
     
     
309. 
     Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
     Circulation. 2025;151:e681.
     PubMed    
     
     
     
310. 
     Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
     Circulation. 2025;151:e680.
     PubMed    
     
     
     
311. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
     Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
     Circulation. 2025;151:578-580.
     PubMed    
     
     
     
312. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
     PubMed     Abstract available
     
     
     
313. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
     Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
     Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
     PubMed     Abstract available
     
     
     
314. NELLIPUDI JA, Kelly B, Hardikar A
     Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
     Circulation. 2025;151:427-429.
     PubMed    
     
     
     
315. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
     Cardiovascular Disease in Anabolic Androgenic Steroid Users.
     Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
     PubMed     Abstract available
     
     
     
316. KIM SM, Kim S, Kim YJ, Kim WY, et al
     Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
     Circulation. 2025;151:421-423.
     PubMed    
     
     
     
317. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
     Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
     Circulation. 2025;151:334-336.
     PubMed    
     
     
     January 2025
318. DAI J, Zhao J, Xu X, Chen Y, et al
     Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
     Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
     PubMed     Abstract available
     
     
     
319. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
     Survivorship After Cardiogenic Shock.
     Circulation. 2025;151:257-271.
     PubMed     Abstract available
     
     
     
320. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
     Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
     Circulation. 2025;151:282-284.
     PubMed    
     
     
     
321. 
     Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2025;151:e30.
     PubMed    
     
     
     
322. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
     Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
     PubMed     Abstract available
     
     
     
323. CHEN JZ, Liang Y, Liang B
     Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e22.
     PubMed    
     
     
     
324. SUN M, He S, Hu J, Zhang Y, et al
     Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e23.
     PubMed    
     
     
     
325. SIDIQI AW, Dad Zada D, Exeer NA
     Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
     Circulation. 2025;151:129-131.
     PubMed    
     
     
     
326. ROGNE T, Gill D
     Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
     Circulation. 2025;151:193-195.
     PubMed    
     
     
     
327. LIU S, Deshmukh V, Meng F, Wang Y, et al
     Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
     Circulation. 2025;151:59-75.
     PubMed     Abstract available
     
     
     
328. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
     Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
     Circulation. 2025;151:98-119.
     PubMed     Abstract available
     
     
     December 2024
329. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
     Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
     Circulation. 2024;150:2046-2069.
     PubMed     Abstract available
     
     
     
330. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
     Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
     Circulation. 2024;150:1990-2003.
     PubMed     Abstract available
     
     
     
331. BIRKENFELD AL, Franks PW, Mohan V
     Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
     Circulation. 2024;150:1910-1912.
     PubMed    
     
     
     
332. LEWANDOWSKI AJ, Rutter MK, Collins R
     Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
     Circulation. 2024;150:1907-1909.
     PubMed    
     
     
     
333. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
     Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2024;150:e481-e500.
     PubMed     Abstract available
     
     
     
334. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
     Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
     Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
     PubMed     Abstract available
     
     
     
335. LINDNER JR, Morello M
     In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
     Circulation. 2024;150:1885-1897.
     PubMed     Abstract available
     
     
     
336. ARMBRUSTER S, Skali H, Wei LJ
     Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
     Circulation. 2024;150:1823-1825.
     PubMed    
     
     
     November 2024
337. QIN D, Modanwal R, Kitsis RN
     Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
     Circulation. 2024;150:1812-1814.
     PubMed    
     
     
     
338. ZHANG W, Zhang J, Wang Z, Li T, et al
     Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2024;150:1791-1811.
     PubMed     Abstract available
     
     
     
339. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
     Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
     Circulation. 2024;150:1815-1817.
     PubMed    
     
     
     
340. JI Y, Zhang MJ, Wang W, Norby FL, et al
     Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
     Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
     PubMed     Abstract available
     
     
     
341. MORROW A, Young R, Abraham GR, Hoole S, et al
     Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
     Circulation. 2024;150:1671-1683.
     PubMed     Abstract available
     
     
     
342. 
     Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
     Circulation. 2024;150:e466.
     PubMed    
     
     
     
343. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
     Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
     Circulation. 2024;150:1720-1731.
     PubMed     Abstract available
     
     
     
344. HO FK, Mark PB, Lees JS, Pell JP, et al
     A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
     Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
     PubMed     Abstract available
     
     
     
345. GREIF R, Bray JE, Djarv T, Drennan IR, et al
     2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
     Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
     PubMed     Abstract available
     
     
     
346. XU X, Zhu H, Xu K
     Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e444.
     PubMed    
     
     
     
347. LIANG Y, Liang B
     Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e443.
     PubMed    
     
     
     
348. YAN Y, Nie S, Montalescot G
     Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e445-e446.
     PubMed    
     
     
     
349. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
     2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
     Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
     PubMed     Abstract available
     
     
     
350. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
     Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
     Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
     PubMed     Abstract available
     
     
     
351. MA C, Ge J, Han Y
     Global Rounds: Advancing Cardiovascular Health in China.
     Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
     PubMed    
     
     
     
352. AVERBUCH T, Stelkia K, Van Spall HGC
     Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
     Circulation. 2024;150:1490-1492.
     PubMed    
     
     
     
353. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
     Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
     PubMed     Abstract available
     
     
     
354. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
     Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
     PubMed     Abstract available
     
     
     October 2024
355. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
     Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
     Circulation. 2024;150:1459-1468.
     PubMed     Abstract available
     
     
     
356. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2024;150:1478-1480.
     PubMed    
     
     
     
357. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
     Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
     PubMed     Abstract available
     
     
     
358. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
     Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
     PubMed     Abstract available
     
     
     
359. SELLKE FW
     Bleeding After Cardiovascular Surgery: A Continuing Problem.
     Circulation. 2024;150:1324-1326.
     PubMed    
     
     
     
360. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
     Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2024;150:1307.
     PubMed    
     
     
     
361. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
     Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
     Circulation. 2024;150:1248-1267.
     PubMed     Abstract available
     
     
     
362. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
     Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
     Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
     PubMed     Abstract available
     
     
     
363. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
     Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
     Circulation. 2024;150:1187-1198.
     PubMed     Abstract available
     
     
     
364. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
     Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
     Circulation. 2024;150:1151-1153.
     PubMed    
     
     
     
365. RUEL M, Chikwe J
     Coronary Artery Bypass Grafting: Past and Future.
     Circulation. 2024;150:1067-1069.
     PubMed    
     
     
     
366. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
     Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
     Circulation. 2024;150:1101-1120.
     PubMed     Abstract available
     
     
     September 2024
367. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
     Immunomodulatory Therapy for Ischemic Heart Disease.
     Circulation. 2024;150:1050-1058.
     PubMed     Abstract available
     
     
     
368. DUAN Z, Huang Z, Lei W, Zhang K, et al
     Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
     Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
     PubMed     Abstract available
     
     
     
369. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
     Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e271-e272.
     PubMed    
     
     
     
370. ZHANG Z
     Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e269-e270.
     PubMed    
     
     
     
371. KOTWAL SS, Perkovic V
     Kidney Disease as a Cardiovascular Disease Priority.
     Circulation. 2024;150:975-977.
     PubMed    
     
     
     
372. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
     2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
     PubMed     Abstract available
     
     
     
373. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
     PubMed     Abstract available
     
     
     
374. LEE DH
     Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
     Circulation. 2024;150:908-910.
     PubMed    
     
     
     
375. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
     Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
     PubMed     Abstract available
     
     
     
376. BUTALA NM, Bucholz EM
     Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
     Circulation. 2024;150:836-837.
     PubMed    
     
     
     
377. BEI Y, Zhu Y, Zhou J, Ai S, et al
     Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
     Circulation. 2024;150:848-866.
     PubMed     Abstract available
     
     
     
378. DIWAN A
     The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
     Circulation. 2024;150:787-790.
     PubMed    
     
     
     
379. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
     Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
     Circulation. 2024;150:770-786.
     PubMed     Abstract available
     
     
     
380. VOLPP KG
     Using Behavioral Science to Improve Cardiovascular Health.
     Circulation. 2024;150:743-745.
     PubMed    
     
     
     
381. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
     Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
     Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
     PubMed    
     
     
     
382. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
     Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
     Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
     PubMed     Abstract available
     
     
     August 2024
383. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
     Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
     PubMed     Abstract available
     
     
     
384. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
     Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
     PubMed     Abstract available
     
     
     
385. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
     Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
     PubMed     Abstract available
     
     
     
386. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
     Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
     PubMed     Abstract available
     
     
     
387. DELWARDE C, Aikawa M
     Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
     Circulation. 2024;150:706-709.
     PubMed    
     
     
     
388. LI J, Sun S, Zhu D, Mei X, et al
     Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
     Circulation. 2024;150:710-723.
     PubMed     Abstract available
     
     
     
389. YU M, Yang Y, Dong SL, Zhao C, et al
     Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
     Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
     PubMed     Abstract available
     
     
     
390. KERN MJ, Seto AH
     Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
     Circulation. 2024;150:598-599.
     PubMed    
     
     
     
391. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
     Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
     Circulation. 2024;150:611-621.
     PubMed     Abstract available
     
     
     
392. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
     SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
     Circulation. 2024;150:622-641.
     PubMed     Abstract available
     
     
     
393. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
     Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
     Circulation. 2024;150:580-582.
     PubMed    
     
     
     
394. MOSLEHI JJ
     Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
     Circulation. 2024;150:513-515.
     PubMed     Abstract available
     
     
     
395. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
     Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
     PubMed     Abstract available
     
     
     
396. LIN Y, Gil CH, Banno K, Yokoyama M, et al
     ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
     Circulation. 2024;150:451-465.
     PubMed     Abstract available
     
     
     
397. BITTNER V
     Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
     Circulation. 2024;150:435-438.
     PubMed    
     
     
     
398. JOYNT MADDOX KE
     Health Economics of Cardiovascular Disease in the United States.
     Circulation. 2024;150:419-421.
     PubMed    
     
     
     
399. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
     Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
     PubMed     Abstract available
     
     
     July 2024
400. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;150:e105.
     PubMed    
     
     
     
401. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
     Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
     Circulation. 2024;150:317-335.
     PubMed     Abstract available
     
     
     
402. ARMSTRONG PW
     Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
     Circulation. 2024;150:258-260.
     PubMed    
     
     
     
403. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
     Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
     Circulation. 2024;150:250-252.
     PubMed    
     
     
     
404. WANG Y, Chen GC, Wang Z, Luo K, et al
     Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
     Circulation. 2024;150:215-229.
     PubMed     Abstract available
     
     
     
405. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
     Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
     Circulation. 2024;150:243-245.
     PubMed    
     
     
     
406. ADEDINSEWO D
     Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
     Circulation. 2024;150:174-176.
     PubMed    
     
     
     
407. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
     Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
     Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
     PubMed     Abstract available
     
     
     
408. ABBARA S, Shaw LJ
     Past, Present, and Future of CTA.
     Circulation. 2024;150:87-90.
     PubMed    
     
     
     
409. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
     Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
     Circulation. 2024;150:165-167.
     PubMed    
     
     
     
410. KUEHN BM
     Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
     Circulation. 2024;150:162-164.
     PubMed    
     
     
     
411. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
     Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
     Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
     PubMed     Abstract available
     
     
     
412. BERRY C, Sidik NP, McEntegart MB
     Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e5-e6.
     PubMed    
     
     
     
413. NISHI T, Saito Y, Kobayashi Y
     Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e3-e4.
     PubMed    
     
     
     June 2024
414. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
     Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
     PubMed     Abstract available
     
     
     
415. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
     Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
     PubMed     Abstract available
     
     
     
416. LIU T, Hao Y, Zhang Z, Zhou H, et al
     Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
     Circulation. 2024;149:2002-2020.
     PubMed     Abstract available
     
     
     
417. JHA AK
     Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
     Circulation. 2024;149:e1415-e1416.
     PubMed    
     
     
     
418. ZHANG S, Zhang Y, Duan X, Wang B, et al
     Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
     Circulation. 2024;149:1982-2001.
     PubMed     Abstract available
     
     
     
419. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
     Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
     Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
     PubMed     Abstract available
     
     
     
420. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
     Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
     Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
     PubMed     Abstract available
     
     
     
421. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1411.
     PubMed    
     
     
     
422. HUNDLEY WG
     Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
     Circulation. 2024;149:1859-1861.
     PubMed    
     
     
     
423. ANDREOTTI F, Burzotta F, Maggioni AP
     Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
     Circulation. 2024;149:e1312.
     PubMed    
     
     
     
424. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
     Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
     Circulation. 2024;149:1855-1857.
     PubMed    
     
     
     
425. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
     Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
     PubMed     Abstract available
     
     
     
426. MORAN AE, Goldman L
     Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
     Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
     PubMed    
     
     
     
427. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
     PubMed     Abstract available
     
     
     May 2024
428. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
     Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
     Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
     PubMed     Abstract available
     
     
     
429. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
     Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
     Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
     PubMed     Abstract available
     
     
     
430. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
     Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
     Circulation. 2024;149:1729-1748.
     PubMed     Abstract available
     
     
     
431. ZHAI X, Cao S, Wang J, Qiao B, et al
     Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
     Circulation. 2024;149:1752-1769.
     PubMed     Abstract available
     
     
     
432. 
     Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1218.
     PubMed    
     
     
     
433. SATTAR N, Neeland IJ, McGuire DK
     Obesity and Cardiovascular Disease: A New Dawn.
     Circulation. 2024;149:1621-1623.
     PubMed    
     
     
     
434. ZHU Q, Scherer PE
     Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
     Circulation. 2024;149:1624-1626.
     PubMed    
     
     
     
435. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
     Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
     PubMed     Abstract available
     
     
     
436. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
     Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
     PubMed     Abstract available
     
     
     
437. 
     Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
     Circulation. 2024;149:e1189-e1190.
     PubMed    
     
     
     
438. TANG WHW, Hazen SL
     Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
     Circulation. 2024;149:1543-1545.
     PubMed    
     
     
     
439. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
     Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
     Circulation. 2024;149:1536-1539.
     PubMed    
     
     
     April 2024
440. KELHAM M, Mathur A, Jones DA
     Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1133.
     PubMed    
     
     
     
441. APOSTOLOS A, Karamasis GV, Tsigkas G
     Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1132.
     PubMed    
     
     
     
442. ZAMAN S, Edwards NC, Chew DP
     Global Rounds: Cardiovascular Care in Australia and New Zealand.
     Circulation. 2024;149:1402-1404.
     PubMed    
     
     
     
443. SOLOMON CG, Landrigan PJ
     Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
     Circulation. 2024;149:1400-1401.
     PubMed    
     
     
     
444. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
     Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
     Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
     PubMed     Abstract available
     
     
     
445. GIRI J, Kaneko T
     Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
     Circulation. 2024;149:1339-1340.
     PubMed    
     
     
     
446. SHAH SH, Gerszten RE
     Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
     Circulation. 2024;149:1323-1325.
     PubMed    
     
     
     
447. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
     Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
     Circulation. 2024;149:1341-1353.
     PubMed     Abstract available
     
     
     
448. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1128.
     PubMed    
     
     
     
449. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
     Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
     PubMed     Abstract available
     
     
     
450. PATEL SM, Kang YM, Im K, Neuen BL, et al
     Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
     PubMed     Abstract available
     
     
     
451. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
     Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
     PubMed     Abstract available
     
     
     
452. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
     Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
     PubMed     Abstract available
     
     
     
453. CHO L, Plutzky J, Brennan D, Louie MJ, et al
     Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
     PubMed    
     
     
     
454. MAEHARA A, Sugizaki Y
     Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
     Circulation. 2024;149:1087-1089.
     PubMed    
     
     
     
455. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
     Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
     Circulation. 2024;149:e1051-e1065.
     PubMed     Abstract available
     
     
     
456. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
     Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
     Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
     PubMed    
     
     
     March 2024
457. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
     Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
     Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
     PubMed     Abstract available
     
     
     
458. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
     Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
     Circulation. 2024;149:1033-1052.
     PubMed     Abstract available
     
     
     
459. SERRUYS PW, Revaiah PC
     The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
     Circulation. 2024;149:973-978.
     PubMed    
     
     
     
460. FENG J, Li Y, Li Y, Yin Q, et al
     Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
     Circulation. 2024;149:1004-1015.
     PubMed     Abstract available
     
     
     
461. 
     Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2024;149:e1023.
     PubMed    
     
     
     
462. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
     Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
     Circulation. 2024;149:1056-1058.
     PubMed    
     
     
     
463. TENG Z, Ma Y, Ma X
     Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e960-e961.
     PubMed    
     
     
     
464. FRANGOGIANNIS NG
     Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e962-e963.
     PubMed    
     
     
     
465. MARANO P, Mouapi K, Kim A, Mastali M, et al
     Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
     Circulation. 2024;149:970-972.
     PubMed    
     
     
     
466. EVERETT BM
     The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
     Circulation. 2024;149:914-916.
     PubMed    
     
     
     
467. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
     A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
     Circulation. 2024;149:902-904.
     PubMed    
     
     
     
468. JUNCA G, Delgado V
     Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
     Circulation. 2024;149:822-824.
     PubMed    
     
     
     
469. HEUTS S, Myers PO, Siepe M
     Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:892-893.
     PubMed    
     
     
     
470. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
     Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:894-895.
     PubMed    
     
     
     
471. ZIMMERMANN FM, Ding VY, Fearon WF
     Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:896.
     PubMed    
     
     
     
472. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
     Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
     PubMed     Abstract available
     
     
     
473. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
     Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
     Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
     PubMed     Abstract available
     
     
     
474. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
     The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
     Circulation. 2024;149:732-733.
     PubMed    
     
     
     
475. RAJAGOPALAN S, Brook RD
     Cardiovascular and Planetary Health: Two Sides of the Same Planet.
     Circulation. 2024;149:729-731.
     PubMed    
     
     
     February 2024
476. CHEN Z, Zhang J, He Y
     Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:725-726.
     PubMed    
     
     
     
477. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
     Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:727-728.
     PubMed    
     
     
     
478. GAFFEY AE, Rollman BL, Burg MM
     Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
     Circulation. 2024;149:641-643.
     PubMed    
     
     
     
479. DZAU VJ, Hodgkinson CP
     RNA Therapeutics for the Cardiovascular System.
     Circulation. 2024;149:707-716.
     PubMed     Abstract available
     
     
     
480. YAN Y, Guo J, Wang X, Wang G, et al
     Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
     Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
     PubMed     Abstract available
     
     
     October 2023
481. GAUDINO M, Sandner S, An KR, Dimagli A, et al
     Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
     Circulation. 2023;148:1305-1315.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum